CMS Changes Accreditation Requirements For All DMEPOS Suppliers Effective January 1, 2026.

Published in Government Relations on December 12, 2025

As we shared last week, CMS finalized the DMEPOS accreditation rule change that requires Accrediting Organizations (AOs) to survey and recredential DMEPOS suppliers annually, instead of every three years. This change is outside of competitive bidding and applies to all DMEPOS suppliers as a condition of Medicare enrollment. 

VGM Group is in frequent communication with the AOs regarding the rule specifics and implementation status. The AOs confirmed they are actively engaged with CMS, having met in aggregate earlier this week, at which CMS clarified when the annual survey and reaccreditation cycle will begin. CMS also recently published a Provision Summary and Q&A document clarifying several aspects of the change, most notably: 

“Frequency of Surveys and Reaccreditation – DMEPOS suppliers have long been required to be resurveyed and reaccredited at least every 36 months (3 years). The final rule reduces the survey and reaccreditation period to at least once every 12 months. 

  • A DMEPOS supplier’s annual resurvey and reaccreditation cycle will not begin until the expiration of the supplier’s current reaccreditation 3-year cycle (if issued prior to the final rule effective date). To illustrate, suppose a supplier was initially accredited or reaccredited for a 3-year period effective June 1, 2023. For purposes of the implementation of our new annual resurvey/reaccreditation requirement – June 1, 2026, is the date: (1) its current accreditation expired; and (2) on which its annual resurvey/reaccreditation cycle begins. Accordingly, the supplier would have to be resurveyed and reaccredited at least once by June 1, 2027, again by June 1, 2028, and so forth. The dates used in this example are not meant to imply that all accreditations must be in effect for exactly 3 years. AOs may issue reaccreditation renewals prior to the expiration date of the current period. 
  • In addition, DMEPOS suppliers seeking initial accreditation for the first time on or after the effective date of this final rule must thereafter be resurveyed and reaccredited annually. If, therefore, a new supplier became initially accredited effective June 1, 2026, it would have to be resurveyed and reaccredited by June 1, 2027, and at least once every 12 months thereafter.” 

"Q6: How long will my current accreditation last? Will it be cut short by the annual survey/reaccreditation requirement? 

A: A DMEPOS supplier’s annual resurvey and reaccreditation cycle will not begin until the expiration of the supplier’s current 3-year accreditation cycle (issued prior to the final rule effective date). More information on this issue will be provided in the coming weeks. 

Q7: Will CMS still allow sampling? 

A: Sampling allows large chains to have a percentage of their locations surveyed. CMS will allow sampling moving forward. Current methodologies will be allowed to continue, and CMS will engage with stakeholders prior to making any large shifts in sampling methodology in the future."

Suppliers should contact their AO for specific questions about their current accreditation.

Find the Final Rule, CMS Fact Sheet, and other resources on VGM’s Competitive Bidding Resource Page and van Halem Group - Competitive Bidding Program

From Our Experts

CMS Rule Phases Out Fax Machines, Snail Mail to Save Taxpayers $781.98 Million a Year thumbnail CMS Rule Phases Out Fax Machines, Snail Mail to Save Taxpayers $781.98 Million a Year As reported by CMS: “The Centers for Medicare & Medicaid Services (CMS) is slashing wasteful spending and antiquated paperwork by swapping out faxing and mailing for streamlined electronic transactions. This action lets providers spend less time on administrative hassle and more time caring for patients. PAMES Raises Critical Concerns Over Sole-Source Supply Shift thumbnail PAMES Raises Critical Concerns Over Sole-Source Supply Shift PAMES and DME suppliers across Washington are taking an important stand on behalf of both providers and patients. The Tacoma Daily Index recently reported on the state's plan to move to a sole-source contract for incontinence and urological supplies. Under this decision, the Health Care Authority intends to transition all Medicaid recipients to receiving these products from a single vendor. SBA Advocacy: Your Input Matters thumbnail SBA Advocacy: Your Input Matters Make your voice heard about how the CBP has affected your business. New Bipartisan Senate Bill Aims to Improve Access to Diabetes Technology & Education for Medicare Beneficiaries thumbnail New Bipartisan Senate Bill Aims to Improve Access to Diabetes Technology & Education for Medicare Beneficiaries U.S. Senators Jeanne Shaheen (D-NH) and Susan Collins (R-ME), Cochairs of the Senate Diabetes Caucus, have introduced the Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services (DIABETES) Act, S.4037. VGM Reintroduces the Fraud, Waste & Abuse Reporting Resource Center thumbnail VGM Reintroduces the Fraud, Waste & Abuse Reporting Resource Center VGM Government Relations is proud to announce the reintroduction of its Fraud, Waste & Abuse (FWA) Reporting Resource Center—a newly refreshed online hub designed to protect the integrity of the DMEPOS industry and reinforce our unwavering commitment to ethical, compliant care. Celebrating Another DME Champion of Change: Thom Harvill of Above and Beyond Medical thumbnail Celebrating Another DME Champion of Change: Thom Harvill of Above and Beyond Medical We're proud to once again recognize a true Champion of Change in the DME industry: Thom Harvill of Above and Beyond Medical in Tennessee. Thom has dedicated many years to the DME community—consistently showing up, speaking out, and pushing the industry forward. He's the kind of advocate who never stops asking, “Who else can I reach out to about this?” Federal Actions This Week Signal The Administration Is Doubling Down On Its Goal To Eliminate Fraud Waste And Abuse thumbnail Federal Actions This Week Signal The Administration Is Doubling Down On Its Goal To Eliminate Fraud Waste And Abuse This week, the Trump administration, through the Centers for Medicare & Medicaid Services (CMS), announced a significant deferral of federal Medicaid matching funds to Minnesota alongside the release of a new Request for Information (RFI) tied to the administration's Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH) initiative. These actions along with the changes to DMEPOS accreditation and enrollment signal the administration's aggressive posture on Medicaid and Medicare... VGM Response To CMS Moratorium On New DMEPOS Provider thumbnail VGM Response To CMS Moratorium On New DMEPOS Provider The federal moratorium on new DME suppliers presents a defining moment for us as an industry—an opportunity to demonstrate that the VGM members serving patients are the gold standard. We have long shown that our members operate with integrity, excellence in compliance, and unmatched commitment to service, efficiency, and patient outcomes. Now, we must elevate that message.